Form 4: HealthEquity Executive Sells Shares

HealthEquity Inc. EVP, Chief Technology Officer Elimelech Rosner reported a sale of 18,010 common shares on March 31, 2026.

Summary

• Elimelech Rosner, EVP, Chief Technology Officer at HealthEquity, Inc., sold 18,010 shares of common stock on March 31, 2026.
• The transaction was executed at a price of $82.5264 per share.
• Following the transaction, Mr. Rosner beneficially owns 86,265 shares of common stock directly.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the sale of a significant number of shares by a key executive, although the transaction is within normal reporting parameters.

Negatives

• Company executive sold a significant number of shares.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, such as this one from HealthEquity, Inc., are standard disclosures for significant transactions by company insiders. These filings provide transparency into executive stock activity, which can be a factor investors consider when evaluating a company's stock.

Stakeholder Impact

• Shareholders may view the executive's stock sale as a potential negative signal, although the sale is a standard disclosure and does not inherently indicate a lack of confidence.

Key Dates

Keywords

HealthEquity, HQY, Form 4, Insider Trading, Stock Sale, Executive Compensation, Technology Officer